Comparison of Etomidate and Ketamine for Induction During Rapid Sequence Intubation of Adult Trauma Patients

Abstract

Study objective: Induction doses of etomidate during rapid sequence intubation cause transient adrenal dysfunction, but its clinical significance on trauma patients is uncertain. Ketamine has emerged as an alternative for rapid sequence intubation induction. Among adult trauma patients intubated in the emergency department, we compare clinical outcomes among those induced with etomidate and ketamine.

Methods: The study entailed a retrospective evaluation of a 4-year (January 2011 to December 2014) period spanning an institutional protocol switch from etomidate to ketamine as the standard induction agent for adult trauma patients undergoing rapid sequence intubation in the emergency department of an academic Level I trauma center. The primary outcome was hospital mortality evaluated with multivariable logistic regression, adjusted for age, vital signs, and injury severity and mechanism. Secondary outcomes included ICU-free days and ventilator-free days evaluated with multivariable ordered logistic regression using the same covariates.

Results: The analysis included 968 patients, including 526 with etomidate and 442 with ketamine. Hospital mortality was 20.4% among patients induced with ketamine compared with 17.3% among those induced with etomidate (adjusted odds ratio [OR] 1.41; 95% confidence interval [CI] 0.92 to 2.16). Patients induced with ketamine had ICU-free days (adjusted OR 0.80; 95% CI 0.63 to 1.00) and ventilator-free days (adjusted OR 0.96; 95% CI 0.76 to 1.20) similar to those of patients induced with etomidate.

Conclusion: In this analysis spanning an institutional protocol switch from etomidate to ketamine as the standard rapid sequence intubation induction agent for adult trauma patients, patient-centered outcomes were similar for patients who received etomidate and ketamine.

Conflict of interest statement

and Source of Funding: The authors report no conflicts of interest related to the content of this manuscript.

Copyright © 2016 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.

Figures

Figure 1

Flow diagram for generation of the study population.

Figure 2

Association between induction agent received (ketamine vs etomidate) and hospital mortality by subgroup population. Figure Abbreviations: TBI, traumatic brain injury; GCS, Glasgow Coma Scale; ISS, Injury Severity Score; SBP, systolic blood pressure (mm Hg); aOR, adjusted odds ratio; CI, confidence interval. a Adjusted for: age; gender; emergency department presentation heart rate, systolic blood pressure, and Glasgow Coma Scale score; Injury Severity Score; and injury mechanism

Figure 3

Interrupted time series analysis. (A) Percentage of patients receiving etomidate and ketamine [left axis] and median Injury Severity Score (ISS) [right axis] during bimonthly intervals. (B) Segmented regression analysis displaying hospital mortality during bimonthly intervals. Each dot represents the percentage of patients intubated during specific bimonthly intervals who died. The dotted line represents a lowess curve fit to the data. Solid dark lines represent best-fit linear regression lines during the etomidate period (slope: −0.4, 95% CI: −1.8, 1.0) and ketamine period (slope: 0.7, 95% CI: −0.7, 2.1).